Piramal Pharma Limited (NSE:PPLPHARMA) — Stock Price

Rs213.61 INR
▲ 1.94% today

Piramal Pharma Limited (NSE:PPLPHARMA) is currently trading at Rs213.61 INR, up 1.94% today. Over the past 52 weeks, shares have ranged between Rs133.27 and Rs213.61. This page tracks Piramal Pharma Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PPLPHARMA company net worth.

Piramal Pharma Limited (PPLPHARMA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Piramal Pharma Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Piramal Pharma Limited Income Statement — Revenue, Profit & Earnings by Year

Piramal Pharma Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs88.69 Billion Rs90.61 Billion Rs81.06 Billion Rs70.32 Billion Rs64.72 Billion
Cost of Revenue Rs64.86 Billion Rs35.72 Billion Rs32.59 Billion Rs30.00 Billion Rs26.80 Billion
Gross Profit Rs23.83 Billion Rs54.89 Billion Rs48.48 Billion Rs40.32 Billion Rs37.91 Billion
Research & Development — Rs971.30 Million Rs1.01 Billion Rs863.60 Million Rs1.28 Billion
SG&A — Rs23.40 Billion Rs2.63 Billion Rs2.32 Billion Rs1.91 Billion
Total Operating Expenses Rs22.93 Billion Rs48.10 Billion Rs43.86 Billion Rs40.80 Billion Rs34.26 Billion
Operating Income Rs903.80 Million Rs6.79 Billion Rs4.62 Billion Rs-479.70 Million Rs3.65 Billion
EBITDA Rs9.22 Billion Rs16.49 Billion Rs13.67 Billion Rs8.94 Billion Rs12.60 Billion
EBIT Rs903.80 Million Rs8.33 Billion Rs6.26 Billion Rs2.18 Billion Rs6.74 Billion
Interest Expense Rs3.41 Billion Rs4.22 Billion Rs4.47 Billion Rs3.44 Billion Rs1.98 Billion
Income Before Tax Rs-1.76 Billion Rs4.15 Billion Rs1.79 Billion Rs-1.20 Billion Rs4.85 Billion
Income Tax Expense Rs1.50 Billion Rs3.24 Billion Rs1.61 Billion Rs663.10 Million Rs1.09 Billion
Net Income Rs-3.26 Billion Rs911.30 Million Rs178.20 Million Rs-1.86 Billion Rs3.76 Billion

Piramal Pharma Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Piramal Pharma Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs179.65 Billion Rs156.78 Billion Rs153.12 Billion Rs145.23 Billion Rs127.97 Billion
Total Current Assets Rs71.92 Billion Rs57.97 Billion Rs54.64 Billion Rs48.35 Billion Rs40.67 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs1.32 Billion Rs195.60 Million Rs1.45 Billion Rs1.00 Million Rs543.20 Million
Net Receivables Rs21.58 Billion Rs23.50 Billion Rs21.51 Billion Rs18.14 Billion Rs18.25 Billion
Inventory Rs30.64 Billion Rs23.13 Billion Rs21.76 Billion Rs16.81 Billion Rs13.89 Billion
Property, Plant & Equipment — — — — —
Goodwill Rs12.57 Billion Rs11.48 Billion Rs11.23 Billion Rs11.08 Billion Rs10.30 Billion
Total Liabilities Rs98.02 Billion Rs75.52 Billion Rs74.00 Billion Rs77.49 Billion Rs61.00 Billion
Total Current Liabilities Rs47.58 Billion Rs37.66 Billion Rs43.69 Billion Rs38.43 Billion Rs30.33 Billion
Long-term Debt Rs43.00 Billion Rs32.14 Billion Rs24.84 Billion Rs33.84 Billion Rs26.22 Billion
Net Debt Rs44.51 Billion Rs43.55 Billion Rs43.53 Billion Rs54.41 Billion Rs39.00 Billion
Total Stockholder Equity Rs81.63 Billion Rs81.25 Billion Rs79.11 Billion Rs67.73 Billion Rs66.97 Billion
Retained Earnings — Rs10.49 Billion Rs9.71 Billion Rs9.56 Billion Rs11.59 Billion

Piramal Pharma Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Piramal Pharma Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs14.00 Billion Rs8.92 Billion Rs10.05 Billion Rs4.84 Billion Rs2.55 Billion
Capital Expenditures Rs8.90 Billion Rs6.64 Billion Rs7.12 Billion Rs9.65 Billion Rs2.01 Billion
Free Cash Flow Rs5.10 Billion Rs2.28 Billion Rs2.92 Billion Rs-4.81 Billion Rs546.90 Million
Investing Cash Flow Rs-8.69 Billion Rs-4.77 Billion Rs-4.34 Billion Rs-13.39 Billion Rs-18.12 Billion
Financing Cash Flow Rs2.57 Billion Rs-4.41 Billion Rs-4.22 Billion Rs8.18 Billion Rs9.06 Billion
Dividends Paid Rs-185.50 Million Rs-144.70 Million — Rs670.00 Million Rs500.00 Million
Stock-Based Compensation Rs417.20 Million Rs480.00 Million Rs274.70 Million Rs0.00 —
Depreciation Rs8.31 Billion Rs8.16 Billion Rs7.41 Billion Rs6.77 Billion Rs1.31 Billion
Change in Cash Rs7.22 Billion Rs-368.70 Million Rs1.66 Billion Rs-319.50 Million Rs-620.80 Million

Piramal Pharma Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Piramal Pharma Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 27, 2026 — -0.43 —
Apr 28, 2026 1.33 0.75 +77.33%
Jan 28, 2026 -0.72 -0.07 -928.57%
Nov 05, 2025 -0.75 -0.29 -158.62%
Jul 28, 2025 -0.62 -1.00 +38.00%
May 14, 2025 1.16 1.25 -7.20%
May 10, 2024 1.00 — —
Jan 30, 2024 0.34 — —